Embodiments described herein are related to a catheter suitable for insertion into a vein of a patient. A catheter is a conduit or tube that is inserted into a body cavity, duct or blood vessel. Catheters may be used for various processes in which bodily fluids, medicaments, or other solutions are introduced and removed from the body, such as perfusion, infusion, apheresis, hemodialysis, chemotherapy, or other processes known in the art.
In one embodiment, a catheter includes a catheter body extending between a distal end and a proximal end and defining at least one lumen, a first portion and a second portion, and an arcuate transition region extending between the first portion and the second portion, such that the arcuate transition region is configured to be at or near an insertion site into the body of a patient, the arcuate transition region including an exterior angle greater than 180 degrees.
In another embodiment, a catheter includes a catheter body extending between a distal end and a proximal end and defining two lumens, a first portion and a second portion, and an arcuate transition region extending between the first portion and the second portion; wherein at least a majority of the first portion is configured to be disposed outside the body of a patient and, wherein at least a segment of the second portion has a length suitable for insertion inside the body of the patient, and wherein the exterior angle between a central axis of the first portion and a central axis of the second portion is greater than 180 degrees.
In another embodiment, a catheter includes a catheter body extending between a distal end and a proximal end and defining at least two lumens, a first portion and a second portion, and an arcuate transition region extending between the first portion and the second portion, wherein the arcuate transition region includes an exterior angle greater than 180 degrees, at least one transformation region between the first portion and the second portion within which the position of a septum dividing the two lumens at least partially changes, and a separation angle formed between a central axis of the first portion and a central axis of the second portion, wherein the separation angle is no more than about 90 degrees.
Understanding that drawings depict only typical embodiments of the disclosure and are not therefore to be considered to be limiting of its scope, the present embodiments will be described and explained with additional specificity and detail through the use of the accompanying drawings as listed below.
Generally, one aspect of the instant disclosure relates to a catheter including an arcuate transition region. Another aspect of the instant disclosure relates to a transformation region within which an orientation of at least one lumen comprising the catheter changes. In addition, a catheter including an arcuate transition region and/or at least one transformation region may include at least one proximal connection structure for facilitating fluid communication with an associated lumen of the catheter and at least one distal leg or portion.
The relative term “distal” refers to those portions of a catheter and those portions of components of the catheter that are nearer, relatively, to an insertion end of the catheter, that is, the end of the catheter that is inserted into an area of a patient's body, such as a blood vessel. In addition, the relative term “proximal” refers to those portions of a catheter and those portions of components of the catheter that are farther, relatively, from the insertion end of the catheter. In one aspect of the instant disclosure, a distal portion of the catheter may cross over or intersect with a proximal portion of the catheter. In addition, optionally, a selected exterior angle may be formed between a central axis of a first portion of the catheter and a central axis of a second portion of the catheter.
As mentioned above, one aspect of the instant disclosure relates to a catheter including an arcuate transition region. Such a catheter may be used for various processes in which bodily fluids, medicaments, or other solutions are introduced and removed from the body, such as perfusion, infusion, apheresis, hemodialysis, chemotherapy, or other processes known in the art. For example, a catheter may be utilized for a hemodialysis catheterization, such as the internal jugular vein catheterization. However, it should be understood by one skilled in the art based on this disclosure, that a catheter can be structured (e.g., increasing or decreasing the catheter size and/or shape, changing a number of lumens defined by the catheter, selecting materials comprising a catheter, etc.) such that the catheter can be beneficially used for a selected medical application in which fluids are introduced and/or removed from the body.
For example,
In one embodiment, the arcuate transition region 90 is configured to be at or near an insertion site into the body of a patient. The arcuate transition region 90 near the insertion site indicates that it is located at a position adjacent or close to the location where the catheter enters the body of a patient. The arcuate transition region near the insertion site can be located adjacent to the insertion site on either the interior of the body or the exterior of the body. For example, in one exemplary embodiment the arcuate transition region near the insertion site may be disposed within the body at a location within 5 cm of the insertion site. One having skill in the art would appreciate that “near the insertion site” is a relative term and may depend, in part, on the size of the arcuate region and the catheter used.
In one embodiment, at least a majority of the first portion 70 is configured to be disposed outside the body of a patient and at least a segment of the second portion 70 has a length suitable for insertion inside the body of the patient. In yet another embodiment, the distal end 50 may include a non-helical terminus. In one embodiment, catheter 10 may comprise one or more lumens.
Generally, the instant disclosure contemplates that arcuate transition region 90 may be structured so that first portion 70 is nonparallel with respect to second portion 80.
In one embodiment, an exterior angle formed between the first portion 70 and the second portion 80 may exceed 180°. For example, the angle formed between the first portion 70 and the second portion 80 may range from approximately 180-190°, 190-200°, 200-210°, 210-220°, 220-230°, 230-240°, 240-250°, 250-260°, and 260-270°. In yet another embodiment, an exterior angle formed between the first portion 70 and the second portion 80 may be less than 180°. For example, the angle formed between the first portion 70 and the second portion 80 may range from approximately 0-10°, 10-20°, 20-30°, 30-40°, 40-50°, 50-60°, 60-70°, 70-80°, 80-90°, 100-110°, 110-120°, 120-130°, 130-140°, 140-150°, 150-160°, 160-170°, and 170-180°. More particularly, an exterior angle between the first portion 70 and the second portion 80 may be about 225°.
The instant disclosure generally contemplates, without limitation, that the exterior angle may be measured between any surfaces of the first portion 70 and/or the second portion 80. Variations (i.e., increases or decreases) in the magnitude of a measurement of an exterior angle due to a thickness or size of the first portion 70 and/or the second portion 80 are encompassed by the above-discussed exterior angle embodiments. One of ordinary skill in the art will appreciate that at least a portion of arcuate transition region 90 may form a generally circular arc. The instant disclosure further contemplates that, in other embodiments, at least a portion of arcuate transition region 90 may comprise at least one of the following: a generally elliptical arc, a generally parabolic curve, and a generally concave curve.
In one embodiment, an exterior angle may be measured between a central axis of the first portion 70 and a central axis of the second portion 80. For example, angle θ is shown in
In addition, the instant disclosure also contemplates that, optionally, an arcuate transition region of a catheter may form a separation angle between a first portion of a catheter and a second portion of a catheter that are connected by an arcuate transition region. More specifically,
One of ordinary skill in the art will appreciate that a catheter including an arcuate transition region may include one or both of a selected exterior angle and a selected separation angle. Put another way, an exterior angle and a separation angle may be employed in combination or may be employed separately, without limitation. One of ordinary skill in the art will appreciate that, in one embodiment of a catheter comprising both a separation angle and an exterior angle, at least a portion of arcuate transition region 90 may be substantially helical.
Such a configuration may provide a catheter that is more comfortable and easier to secure to a patient. Additionally or optionally, such a unique shape may act to stabilize the catheter within the tunnel/venotomy region and may prevent pistoning and migration of the catheter prior to tissue ingrowth. Since the transition or path from tunnel track into vein is generally three dimensional and tortuous in nature such a catheter including an arcuate transition region may contour more closely to this transition or path.
In further detail, an arcuate transition region may be capable of handling even relatively tight curves. For example, the catheter can be more easily “rolled” by the doctor prior to placement to adjust where the distal end will end up. As a further note, the catheter may comprise a material (e.g., polyurethane) that significantly softens at body temperature. Thus, in one embodiment, the shape of the catheter may not generate residual stresses (i.e., outward forces) exceeding forces generated by a conventional (e.g., U-shaped) catheters. Conventional catheters are disclosed in U.S. Pat. No. 5,509,897 to Twardowski et al.
In another embodiment, a catheter may comprise a catheter body extending between a distal end and a proximal end and defining a plurality of lumens. Further, the distal end may comprise a plurality of distal end regions that extend generally from a junction region of the catheter body. In addition, the proximal end may comprise a plurality of proximal extension legs. In general, the instant disclosure contemplates, as discussed above, that such a catheter may include an arcuate transition region extending between the first portion and the second portion of the catheter.
For example,
Optionally, at least one of distal end regions 132 and 134 as well as one or more of proximal extension legs 108 and 106 and/or one or more of couplings 112 and 114, may include a visual or palpable indicator (e.g., a marking, a color, a symbol, a raised or indented feature, etc.) to indicate correspondence upon connection of catheter 110 to a fluid moving device. Also, each of proximal extension legs 108 and 106 may optionally include a clamp device, such as clamp devices 119 and 117, for clamping one or both of the proximal extension legs 108 and 106 when the catheter 110 is not connected to a fluid conveying device or when fluid flow through one or both of proximal extension legs 108 and 106 is not desired.
As shown in
One of ordinary skill in the art will understand that proximal extension legs 106 and 108 in combination with couplings 112 and 114, respectively, may be used to connect catheter 110 to a fluid processing or fluid moving device (e.g., a medicine pump, a dialysis machine, etc.). Further, one of ordinary skill in the art will also understand that the first distal end region 132 may be used to remove fluid from a patient (e.g., as a venous extension leg in a hemodialysis application) and second distal end region 134 may be used to introduce fluid into a patient (e.g., as an arterial extension leg in a hemodialysis application). Additionally, the instant disclosure contemplates that the second distal end region 134 may be used to remove fluid from a patient (e.g., as a venous extension leg in a hemodialysis application) and first distal end region 132 may be used to introduce fluid into a patient (e.g., as an arterial extension leg in a hemodialysis application), if desired, without limitation.
The instant disclosure contemplates that arcuate transition region 190 may be configured, as discussed above in relation to any feature or aspect discussed above relative to arcuate transition region 90. Particularly, arcuate transition region 190 may be structured so that a first portion 170 is nonparallel with respect to a second portion 180.
In one embodiment, an exterior angle formed between the first portion 170 and the second portion 180 may exceed 180°. For example, the angle formed between the first portion 170 and the second portion 180 may range from approximately 180-190°, 190-200°, 200-210°, 210-220°, 220-230°, 230-240°, 240-250°, 250-260°, and 260-270°. In yet another embodiment, an exterior angle formed between the first portion 170 and the second portion 180 may be less than 180°. For example, the angle formed between the first portion 170 and the second portion 180 may range from approximately 0-10°, 10-20°, 20-30°, 30-40°, 40-50°, 50-60°, 60-70°, 70-80°, 80-90°, 100-110°, 110-120°, 120-130°, 130-140°, 140-150°, 150-160°, 160-170°, and 170-180°. More particularly, an exterior angle between the first portion 170 and the second portion 180 may be about 225°. Further, one of ordinary skill in the art will appreciate that at least a portion of arcuate transition region 190 may comprise at least one of the following: a substantially circular arc, an elliptical arc, a parabolic curve, and a concave curve.
In addition, the instant disclosure generally contemplates, without limitation, that an exterior angle may be measured between any surfaces of the first portion 170 and/or the second portion 180, and such an exterior angle encompasses variations (i.e., increases or decreases) in the magnitude of the exterior angle due to a thickness or size of the first portion 170 and/or the second portion 180.
In one embodiment, an exterior angle may be measured between a central axis of the first portion 170 and a central axis of the second portion 180. For example, exterior angle θ is shown in
In one embodiment, exterior angle θ may exceed 180°. In another embodiment, exterior angle θ may be about 225°. Further, central axis 163 may cross or intersect with central axis 141 (e.g., for a given reference plane, as shown in the exemplary bottom elevation view of
Optionally, the first distal end region 132 may include one or more apertures formed through the first distal end region 132 in fluid communication with a lumen of catheter 110. Similarly, the second distal end region 134 may include one or more apertures in fluid communication with a lumen of catheter 110. Such one or more apertures formed through one or both first distal end region 132 and second distal end region 134 may facilitate fluid flow into or from the distal end regions 132 and 134.
In another aspect of the instant disclosure, an orientation of a lumen may change along the length of at least a portion of a catheter. For example, a catheter may include at least one region within which an orientation of a lumen changes. Particularly,
Further, catheter 111 may include a transformation region 220, within which an orientation of a lumen at least partially changes. More particularly,
Within transformation region 220, the orientation of lumens 202 and 204 may change between respective orientations shown in
In another embodiment, lumens 202 and 204, and septum 205, may rotate in a clockwise direction relative to a distal direction within transformation region 220 between the orientations shown in
A catheter including at least one transformation region may exhibit at least one selected mechanical property (e.g., a flexibility, moment of inertia, strength, etc.). Also, one of ordinary skill in the art will appreciate that position of septum 205, as shown in
In a further embodiment, a catheter may include a plurality of transformation regions. For example,
The instant disclosure further encompasses any combination of features or attributes described above. For example, in one embodiment, a catheter may include an arcuate transition region and at least one transformation region. More particularly,
While aspects of the instant disclosure are described in relation to one embodiment of a catheter comprising two lumens, the instant disclosure is not so limited and other embodiments and catheter configurations are encompassed by the instant disclosure. For example, a catheter defining a plurality of lumens may comprise a plurality of substantially concentric tubes of varying diameter. In a further embodiment, a catheter may comprise three (or more) lumens. Generally, any lumen configuration known in the art may be utilized in combination with at least one of the following: an arcuate transition region and at least one transformation region. In addition, any distal tip structure as known in the art may comprise a catheter including at least one of the following: an arcuate transition region and at least one transformation region.
For example, any distal tip structure, such as a so-called “stepped-tip,” “split-tip,” or any catheter distal tip structure as known in the art, without limitation, may be included by a catheter comprising at least one of the following: an arcuate transition region and at least one transformation region. For example, in one embodiment, a catheter may include a so-called “stepped tip.” More particularly,
In a further aspect of the instant disclosure, one of ordinary skill in the art will appreciate that a transition region of a catheter may extend between a first portion and second portion of a catheter in a variety of ways. For instance, by way of illustration,
Without further elaboration, it is believed that one skilled in the art can use the preceding description to utilize the present disclosure to its fullest extent. The examples and embodiments disclosed herein are to be construed as merely illustrative and not a limitation of the scope of the present disclosure in any way. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure described herein. In other words, various modifications and improvements of the embodiments specifically disclosed in the description above are within the scope of the appended claims.
This application claims the benefit of U.S. Provisional Application No. 60/744,094, entitled “CATHETER INCLUDING ARCUATE TRANSITION REGION AND/OR AT LEAST ONE TRANSFORMATION REGION,” filed Mar. 31, 2006, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
256590 | Pfarre | Apr 1882 | A |
2175726 | Gebauer | Oct 1939 | A |
2590895 | Scarpellino | Apr 1952 | A |
2910981 | Wilson et al. | Nov 1959 | A |
3055361 | Ballard | Sep 1962 | A |
3256885 | Higgins et al. | Jun 1966 | A |
3434691 | Hamilton | Mar 1969 | A |
3612038 | Halligan | Oct 1971 | A |
3634924 | Blake et al. | Jan 1972 | A |
3677243 | Nerz | Jul 1972 | A |
3720210 | Diettrich | Mar 1973 | A |
3812851 | Rodriguez | May 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3921631 | Thompson | Nov 1975 | A |
3935857 | Co | Feb 1976 | A |
3942528 | Loeser | Mar 1976 | A |
3964488 | Ring et al. | Jun 1976 | A |
3983203 | Corbett | Sep 1976 | A |
4016879 | Mellor | Apr 1977 | A |
4020829 | Willson et al. | May 1977 | A |
4027659 | Slingluff | Jun 1977 | A |
4027668 | Dunn | Jun 1977 | A |
4033331 | Guss et al. | Jul 1977 | A |
4079737 | Miller | Mar 1978 | A |
4099528 | Sorenson et al. | Jul 1978 | A |
4117836 | Erikson et al. | Oct 1978 | A |
4134402 | Mahurkar | Jan 1979 | A |
4180068 | Jacobsen et al. | Dec 1979 | A |
4202332 | Tersteegen et al. | May 1980 | A |
4203436 | Grimsrud | May 1980 | A |
4217895 | Sagae et al. | Aug 1980 | A |
4220813 | Kyle | Sep 1980 | A |
4220814 | Kyle et al. | Sep 1980 | A |
4250880 | Gordon | Feb 1981 | A |
4270535 | Bogue et al. | Jun 1981 | A |
4292976 | Banka | Oct 1981 | A |
4300550 | Gandi et al. | Nov 1981 | A |
4306562 | Osborne | Dec 1981 | A |
4311152 | Modes et al. | Jan 1982 | A |
4352354 | Ujihara et al. | Oct 1982 | A |
4352951 | Kyle | Oct 1982 | A |
4385631 | Uthmann et al. | May 1983 | A |
4392855 | Oreopoulos et al. | Jul 1983 | A |
4402685 | Buhler et al. | Sep 1983 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4405313 | Sisley et al. | Sep 1983 | A |
4417888 | Cosentino et al. | Nov 1983 | A |
D272651 | Mahurkar | Feb 1984 | S |
4451252 | Martin et al. | May 1984 | A |
4451256 | Weikl et al. | May 1984 | A |
4471778 | Toye | Sep 1984 | A |
4493696 | Uldall et al. | Jan 1985 | A |
4508535 | Joh et al. | Apr 1985 | A |
4531933 | Norton et al. | Jul 1985 | A |
4543087 | Sommercorn et al. | Sep 1985 | A |
4549879 | Groshong et al. | Oct 1985 | A |
4557261 | Rugheimer et al. | Dec 1985 | A |
4563180 | Jervis et al. | Jan 1986 | A |
4568329 | Mahurkar | Feb 1986 | A |
4568338 | Todd | Feb 1986 | A |
4576199 | Svensson et al. | Mar 1986 | A |
4581012 | Brown et al. | Apr 1986 | A |
4583968 | Mahurkar | Apr 1986 | A |
4595005 | Jinotti | Jun 1986 | A |
4596559 | Fleischhacker | Jun 1986 | A |
4619643 | Bai et al. | Oct 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4626240 | Edelman et al. | Dec 1986 | A |
4643711 | Bates | Feb 1987 | A |
4648868 | Hardwick et al. | Mar 1987 | A |
4668221 | Luther | May 1987 | A |
4671796 | Groshong et al. | Jun 1987 | A |
4675004 | Hadford et al. | Jun 1987 | A |
4681564 | Landreneau | Jul 1987 | A |
4681570 | Dalton | Jul 1987 | A |
4682978 | Martin et al. | Jul 1987 | A |
4687471 | Twardowski et al. | Aug 1987 | A |
4687741 | Farrell et al. | Aug 1987 | A |
4692141 | Mahurkar | Sep 1987 | A |
4694838 | Wijayarthna et al. | Sep 1987 | A |
4701159 | Brown et al. | Oct 1987 | A |
4701166 | Groshong et al. | Oct 1987 | A |
4735620 | Ruiz | Apr 1988 | A |
4738667 | Galloway | Apr 1988 | A |
4739768 | Engelson | Apr 1988 | A |
4772268 | Bates | Sep 1988 | A |
4772269 | Twardowski et al. | Sep 1988 | A |
4773431 | Lodomirski | Sep 1988 | A |
4784639 | Patel | Nov 1988 | A |
4789000 | Aslanian | Dec 1988 | A |
4790809 | Kuntz | Dec 1988 | A |
4795439 | Guest | Jan 1989 | A |
4808155 | Mahurkar | Feb 1989 | A |
4808156 | Dean | Feb 1989 | A |
4820349 | Saab | Apr 1989 | A |
4822345 | Danforth | Apr 1989 | A |
4834709 | Banning et al. | May 1989 | A |
4842582 | Mahurkar | Jun 1989 | A |
4846814 | Ruiz | Jul 1989 | A |
4867742 | Calderon | Sep 1989 | A |
4883058 | Ruiz | Nov 1989 | A |
4895561 | Mahurkar | Jan 1990 | A |
4898669 | Tesio et al. | Feb 1990 | A |
4909787 | Danforth | Mar 1990 | A |
4935004 | Cruz | Jun 1990 | A |
4961731 | Bodicky et al. | Oct 1990 | A |
4961809 | Martin et al. | Oct 1990 | A |
4973306 | Ruiz | Nov 1990 | A |
4976703 | Franetzki et al. | Dec 1990 | A |
4981477 | Schon et al. | Jan 1991 | A |
4985014 | Orejola | Jan 1991 | A |
5016640 | Ruiz | May 1991 | A |
5041083 | Tsuchida et al. | Aug 1991 | A |
5041107 | Heil, Jr. | Aug 1991 | A |
5045072 | Castillo et al. | Sep 1991 | A |
5053003 | Dadson et al. | Oct 1991 | A |
5053004 | Markel et al. | Oct 1991 | A |
5053023 | Martin et al. | Oct 1991 | A |
5057073 | Martin et al. | Oct 1991 | A |
5058595 | Kern | Oct 1991 | A |
5084024 | Skinner | Jan 1992 | A |
5098413 | Trudell et al. | Mar 1992 | A |
5141499 | Zappacosta | Aug 1992 | A |
5156592 | Martin et al. | Oct 1992 | A |
5171216 | Dasse et al. | Dec 1992 | A |
5171227 | Twardowski et al. | Dec 1992 | A |
5188619 | Myers | Feb 1993 | A |
5197951 | Mahurkar | Mar 1993 | A |
5209723 | Twardowski et al. | May 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5221256 | Mahurkar | Jun 1993 | A |
5292305 | Boudewijn et al. | Mar 1994 | A |
5306263 | Voda | Apr 1994 | A |
5318588 | Horzewski et al. | Jun 1994 | A |
5324274 | Martin et al. | Jun 1994 | A |
5327905 | Avitall | Jul 1994 | A |
5346471 | Raulerson | Sep 1994 | A |
5350358 | Martin | Sep 1994 | A |
5354271 | Voda | Oct 1994 | A |
5354297 | Avitall | Oct 1994 | A |
5358479 | Wilson | Oct 1994 | A |
5358493 | Schweich, Jr. et al. | Oct 1994 | A |
5374245 | Mahurkar | Dec 1994 | A |
5380276 | Miller et al. | Jan 1995 | A |
5395316 | Martin et al. | Mar 1995 | A |
5401258 | Voda | Mar 1995 | A |
5403291 | Abrahamson | Apr 1995 | A |
5405320 | Twardowski et al. | Apr 1995 | A |
5405341 | Martin et al. | Apr 1995 | A |
5445625 | Voda | Aug 1995 | A |
5507995 | Schweich, Jr. et al. | Apr 1996 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5509902 | Raulerson | Apr 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5569197 | Helmus et al. | Oct 1996 | A |
5569218 | Berg | Oct 1996 | A |
5599311 | Raulerson | Feb 1997 | A |
5624413 | Markel et al. | Apr 1997 | A |
5650759 | Hittman et al. | Jul 1997 | A |
5685867 | Twardowski et al. | Nov 1997 | A |
5718678 | Fleming, III | Feb 1998 | A |
5718692 | Schon et al. | Feb 1998 | A |
5741233 | Riddle et al. | Apr 1998 | A |
5755760 | Maguire et al. | May 1998 | A |
5776111 | Tesio et al. | Jul 1998 | A |
5795326 | Siman | Aug 1998 | A |
5830184 | Basta | Nov 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5868700 | Voda | Feb 1999 | A |
5885259 | Berg | Mar 1999 | A |
5897537 | Berg et al. | Apr 1999 | A |
5902282 | Balbierz | May 1999 | A |
5941872 | Berg | Aug 1999 | A |
5944732 | Raulerson et al. | Aug 1999 | A |
5947953 | Ash et al. | Sep 1999 | A |
5957961 | Maguire et al. | Sep 1999 | A |
5961486 | Twardowski et al. | Oct 1999 | A |
5968009 | Siman | Oct 1999 | A |
5989206 | Prosl et al. | Nov 1999 | A |
5989213 | Maginot | Nov 1999 | A |
6001079 | Pourchez et al. | Dec 1999 | A |
6002955 | Willems et al. | Dec 1999 | A |
6004280 | Buck et al. | Dec 1999 | A |
6024693 | Schock et al. | Feb 2000 | A |
6033382 | Basta | Mar 2000 | A |
6083213 | Voda | Jul 2000 | A |
6156016 | Maginot | Dec 2000 | A |
6190349 | Ash et al. | Feb 2001 | B1 |
6190371 | Maginot et al. | Feb 2001 | B1 |
6277100 | Raulerson et al. | Aug 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6293927 | McGuckin, Jr. | Sep 2001 | B1 |
6342120 | Basta | Jan 2002 | B1 |
6356790 | Maguire et al. | Mar 2002 | B1 |
6475195 | Voda | Nov 2002 | B1 |
6475207 | Maginot et al. | Nov 2002 | B1 |
6533763 | Schneiter | Mar 2003 | B1 |
6551281 | Raulerson et al. | Apr 2003 | B1 |
6585705 | Maginot et al. | Jul 2003 | B1 |
6595966 | Davey et al. | Jul 2003 | B2 |
6595983 | Voda | Jul 2003 | B2 |
6620118 | Prosl et al. | Sep 2003 | B1 |
6638242 | Wilson et al. | Oct 2003 | B2 |
6682519 | Schon | Jan 2004 | B1 |
6695832 | Schon et al. | Feb 2004 | B2 |
6719749 | Schweikert et al. | Apr 2004 | B1 |
6723084 | Maginot et al. | Apr 2004 | B1 |
D489452 | Schweikert | May 2004 | S |
6730096 | Basta | May 2004 | B2 |
D491265 | Schweikert | Jun 2004 | S |
6743218 | Maginot et al. | Jun 2004 | B2 |
6749580 | Work et al. | Jun 2004 | B2 |
6796991 | Nardeo | Sep 2004 | B2 |
D498299 | Schweikert | Nov 2004 | S |
6814718 | McGuckin, Jr. et al. | Nov 2004 | B2 |
6823617 | Schweikert | Nov 2004 | B2 |
6858019 | McGuckin et al. | Feb 2005 | B2 |
6881211 | Schweikert et al. | Apr 2005 | B2 |
D505202 | Chesnin | May 2005 | S |
6911014 | Wentling et al. | Jun 2005 | B2 |
6916051 | Fisher | Jul 2005 | B2 |
6926669 | Stewart et al. | Aug 2005 | B1 |
6926721 | Basta | Aug 2005 | B2 |
6939328 | Raulerson | Sep 2005 | B2 |
6969381 | Voorhees | Nov 2005 | B2 |
6986752 | McGuckin, Jr. et al. | Jan 2006 | B2 |
6991625 | Gately et al. | Jan 2006 | B1 |
D515211 | Chesnin | Feb 2006 | S |
7008412 | Maginot | Mar 2006 | B2 |
7011645 | McGuckin, Jr. et al. | Mar 2006 | B2 |
7018374 | Schon et al. | Mar 2006 | B2 |
7066925 | Gately et al. | Jun 2006 | B2 |
D525359 | Stephens | Jul 2006 | S |
7074213 | McGuckin, Jr. et al. | Jul 2006 | B2 |
7077829 | McGuckin, Jr. et al. | Jul 2006 | B2 |
D530420 | Chesnin | Oct 2006 | S |
7115134 | Chambers | Oct 2006 | B2 |
7163531 | Seese et al. | Jan 2007 | B2 |
7172571 | Moskowitz et al. | Feb 2007 | B2 |
7220246 | Raulerson et al. | May 2007 | B2 |
7223263 | Seno | May 2007 | B1 |
D544600 | Wentling | Jun 2007 | S |
D546446 | Chesnin | Jul 2007 | S |
7261708 | Raulerson | Aug 2007 | B2 |
7393339 | Zawacki et al. | Jul 2008 | B2 |
7494478 | Itou et al. | Feb 2009 | B2 |
7695450 | Twardowski et al. | Apr 2010 | B1 |
7799013 | Gandras | Sep 2010 | B2 |
7867218 | Voda | Jan 2011 | B1 |
7976518 | Shaughnessy et al. | Jul 2011 | B2 |
8021321 | Zawacki | Sep 2011 | B2 |
8029457 | Ash et al. | Oct 2011 | B2 |
8066660 | Gregersen et al. | Nov 2011 | B2 |
8092415 | Moehle | Jan 2012 | B2 |
8152951 | Zawacki et al. | Apr 2012 | B2 |
8206371 | Nimkar et al. | Jun 2012 | B2 |
8292841 | Gregersen | Oct 2012 | B2 |
8323227 | Hamatake et al. | Dec 2012 | B2 |
8409191 | Avitall et al. | Apr 2013 | B2 |
8500939 | Nimkar et al. | Aug 2013 | B2 |
8540661 | Gregersen | Sep 2013 | B2 |
8597275 | Nimkar et al. | Dec 2013 | B2 |
8696614 | Gregersen et al. | Apr 2014 | B2 |
8808227 | Zawacki et al. | Aug 2014 | B2 |
8827943 | Angheloiu et al. | Sep 2014 | B2 |
8876754 | Ranchod et al. | Nov 2014 | B2 |
8894601 | Moehle et al. | Nov 2014 | B2 |
8992454 | Anand | Mar 2015 | B2 |
9126011 | Ash et al. | Sep 2015 | B2 |
9131956 | Shaughnessy et al. | Sep 2015 | B2 |
9155860 | Ash et al. | Oct 2015 | B2 |
9174019 | Gregersen | Nov 2015 | B2 |
9233200 | Gregersen et al. | Jan 2016 | B2 |
20020032411 | Basta | Mar 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20030036698 | Kohler et al. | Feb 2003 | A1 |
20030066218 | Schweikert | Apr 2003 | A1 |
20030093027 | McGuckin et al. | May 2003 | A1 |
20030093029 | McGuckin et al. | May 2003 | A1 |
20030114832 | Kohler et al. | Jun 2003 | A1 |
20030144623 | Heath et al. | Jul 2003 | A1 |
20040015151 | Chambers | Jan 2004 | A1 |
20040034324 | Seese et al. | Feb 2004 | A1 |
20040034333 | Seese et al. | Feb 2004 | A1 |
20040054321 | Schon et al. | Mar 2004 | A1 |
20040059314 | Schon et al. | Mar 2004 | A1 |
20040075198 | Schweikert et al. | Apr 2004 | A1 |
20040092863 | Raulerson et al. | May 2004 | A1 |
20040097903 | Raulerson | May 2004 | A1 |
20040122416 | Schweikert et al. | Jun 2004 | A1 |
20040186461 | DiMatteo | Sep 2004 | A1 |
20040193098 | Wentling et al. | Sep 2004 | A1 |
20040195131 | Spolidoro | Oct 2004 | A1 |
20040249349 | Wentling | Dec 2004 | A1 |
20050000844 | Schweikert | Jan 2005 | A1 |
20050015007 | Itou et al. | Jan 2005 | A1 |
20050038453 | Raulerson | Feb 2005 | A1 |
20050043684 | Basta et al. | Feb 2005 | A1 |
20050049572 | Schweikert et al. | Mar 2005 | A1 |
20050049628 | Schweikert et al. | Mar 2005 | A1 |
20050054990 | Graft et al. | Mar 2005 | A1 |
20050085765 | Voorhees | Apr 2005 | A1 |
20050096580 | Moskowitz et al. | May 2005 | A1 |
20050096585 | Schon et al. | May 2005 | A1 |
20050096609 | Maginot et al. | May 2005 | A1 |
20050101903 | Kohler et al. | May 2005 | A1 |
20050107770 | Schweikert et al. | May 2005 | A1 |
20050113801 | Gandras | May 2005 | A1 |
20050120523 | Schweikert | Jun 2005 | A1 |
20050124970 | Kunin et al. | Jun 2005 | A1 |
20050137527 | Kunin | Jun 2005 | A1 |
20050137580 | Raulerson et al. | Jun 2005 | A1 |
20050192545 | Voorhees et al. | Sep 2005 | A1 |
20050209583 | Powers et al. | Sep 2005 | A1 |
20050222593 | Markel et al. | Oct 2005 | A1 |
20050234369 | Voorhees | Oct 2005 | A1 |
20050245900 | Ash | Nov 2005 | A1 |
20050261665 | Voorhees | Nov 2005 | A1 |
20060004316 | Difiore et al. | Jan 2006 | A1 |
20060004324 | Ruddell et al. | Jan 2006 | A1 |
20060015072 | Raulerson | Jan 2006 | A1 |
20060015130 | Voorhees et al. | Jan 2006 | A1 |
20060030827 | Raulerson et al. | Feb 2006 | A1 |
20060047267 | Gately et al. | Mar 2006 | A1 |
20060047268 | Stephens | Mar 2006 | A1 |
20060064072 | Gately et al. | Mar 2006 | A1 |
20060095030 | Avitall et al. | May 2006 | A1 |
20060095062 | Stephens | May 2006 | A1 |
20060184142 | Schon et al. | Aug 2006 | A1 |
20060189959 | Schneiter | Aug 2006 | A1 |
20060200111 | Moehle et al. | Sep 2006 | A1 |
20060206094 | Chesnin et al. | Sep 2006 | A1 |
20060253063 | Schweikert | Nov 2006 | A1 |
20060271012 | Canaud et al. | Nov 2006 | A1 |
20070043307 | Raulerson et al. | Feb 2007 | A1 |
20070049960 | Stephens et al. | Mar 2007 | A1 |
20070060866 | Raulerson et al. | Mar 2007 | A1 |
20070073271 | Brucker et al. | Mar 2007 | A1 |
20070135794 | Raulerson et al. | Jun 2007 | A1 |
20070198047 | Schon et al. | Aug 2007 | A1 |
20070219510 | Zinn et al. | Sep 2007 | A1 |
20070225661 | Ash et al. | Sep 2007 | A1 |
20070225682 | Ash et al. | Sep 2007 | A1 |
20070225683 | Raulerson et al. | Sep 2007 | A1 |
20070225684 | Wentling et al. | Sep 2007 | A1 |
20070233017 | Zinn et al. | Oct 2007 | A1 |
20070233018 | Bizup et al. | Oct 2007 | A1 |
20080021417 | Zawacki et al. | Jan 2008 | A1 |
20080039774 | Zawacki et al. | Feb 2008 | A1 |
20080045886 | Hobbs et al. | Feb 2008 | A1 |
20080045894 | Perchik et al. | Feb 2008 | A1 |
20080097339 | Ranchod et al. | Apr 2008 | A1 |
20090018493 | Ash et al. | Jan 2009 | A1 |
20140200524 | Wiley et al. | Jul 2014 | A1 |
Number | Date | Country |
---|---|---|
1092927 | Jan 1981 | CA |
1150122 | Jul 1983 | CA |
545218 | Feb 1932 | DE |
2627850 | Jan 1977 | DE |
2627851 | Jan 1977 | DE |
3736226 | May 1989 | DE |
146777 | Oct 1977 | DK |
0036642 | Sep 1981 | EP |
0081724 | Jun 1983 | EP |
0102342 | Mar 1984 | EP |
0132344 | Jan 1985 | EP |
0242985 | Oct 1987 | EP |
256478 | Feb 1988 | EP |
0263645 | Apr 1988 | EP |
323738 | Jul 1989 | EP |
0386408 | Sep 1990 | EP |
386408 | Sep 1990 | EP |
2069287 | Jun 1993 | ES |
2529083 | Dec 1983 | FR |
2238724 | Jun 1991 | GB |
59034265 | Feb 1984 | JP |
63111833 | May 1988 | JP |
1058263 | Mar 1989 | JP |
1238872 | Sep 1989 | JP |
WO 9115255 | Oct 1991 | WO |
WO-9212754 | Aug 1992 | WO |
WO 9321983 | Nov 1993 | WO |
9624399 | Aug 1996 | WO |
9717102 | May 1997 | WO |
0023137 | Apr 2000 | WO |
0213899 | Feb 2002 | WO |
WO 0230489 | Apr 2002 | WO |
03030960 | Apr 2003 | WO |
Entry |
---|
PCT Written Opinion of the International Searching Authority; International Application No. PCT/US20074/008148. European Patent Office. |
Vas-Cath; Niagara, Dual Lumen Catheter Instructions for Use; Jun. 1997; Canada. |
Vas-Cath; Opti-Flow and Soft-Cell; Dual Lumen Catheter Straight and Pre-Curved (PC) Catheters, with and without VitaCuff; Jun. 16, 1997. |
Bard Access Systems; Power Picc The Universal Picc, Polyurethane PICC with Safety Excalibur Introducer System Instructions for Use; Jul. 2003. |
Bard Access Systems; PowerPicc, The Universal Picc, Polyurethane Radiology Catheters with Microintroducer Set Instructions for Use; Nov. 2003. |
Bard; 135cm Guidewire, Instructions for Use; Mar. 2002, excerpt. |
Bard Access Systems; HemoSplit Long-Term Hemodialysis Catheter, Instructions for Use; Apr. 2003. |
McIntosh, Berry, Thompson, and Durham; Double Lumen Catheter for Use with Artificial Kidney; J.A.M.A.; Feb. 21, 1959; 137/835-138/836. |
Medcomp; Effective Solutions for Vascular Access; Product Line; Apr. 2006; Rev. D. |
Cournand et al. “Double Lumen Catheter for Intravenous and Intracardiac Blood Sampling and Pressure Recording.” Proceedings of the Society for Experimental Biology and Medicine, vol. 60, pp. 73, 1994. |
Cook Critical Care; Cook TPN Pre-Cut Double Lumen Catheters with Off-Set Tips; A000053 1982. |
Raja et al. “Comparison of Double Lumen Subclavian with Single Lumen Catheter—One Year Experience.” Trans American Society of Artificial Internal Organs, vol. XXX 1984. |
Zuniga et al. “Hemodialisis: Accesso Vascular Con Cateter De Doble Lumen.” Rev. Med. Chile; 117: pp. 991-996, 1989. |
Vanherweghem et al. “Complications Related to Subclavian Catheters for Hemodialysis.” American Journal of Nephrol 6, pp. 339-345, 1986. |
Lally et al. “Use of Subclavian Venous Catheter for Short- and Long-term Hemodialysis in Children.” Journal of Pediatric Surgery, vol. 44, No. 7, pp. 603-605, 1987. |
Cheesbrough et al. “A Prospective Study of the Mechanisms of Infection Associated with Hemodialysis Catheters.” The Journal of Infectious Diseases vol. 154, No. 4, pp. 579-589, 1986. |
Ota et al. “A Completely New Poly(ether-urethane) Graft Ideal for Hemodialysis Blood Access.” Trans Am Soc Artif Intern Organs, vol. XXXIII, pp. 129-135, 1987. |
Scribner et al. “Evolution of the Technique of Home Parenteral Nutrition.” Journal of Parenteral and Enteral Nutrition. vol. 3, No. 2, pp. 58-61, 1979. |
Sanders et al. “Experience with Double Lumen Right Atrial Catheters.” American Society of Parenteral and Enteral Nutrition, vol. 6, No. 2., pp. 95-99, 1982. |
Shiley ©; Subclavian Cannulae product brochure, 1986. |
Hickman, Robert O., et al., “A Review of Hemodialysis Catheters and Access Devices.” Dialysis & Transplantation, vol. 16, No. 9, pp. 481 485, 1997. |
Annest, Lon S et al. “Use of a Split-Sheath Vein Introducer for Subclavian Venipuncture in the Placement of Silicone Catheters for Chronic Venous Access.” The American Journal of Surgery, vol. 144, pp. 367-369, 1982. |
McDowell, Donald E., et al., “A Simplified technique for percutaneous insertion of permanenet vascular access catheters in patients requiring chronic hemodialysis.” Section of Vascular Surgery, Department of Surgery, West Virginia University Medical Center, Morgantown, WV 26505. |
Sims, Terran W., et al., “Successful Utilization of Subclavian Catheters for Hemodialysis and Apheresis Access”, AANNT Journal, vol. 10, No. 6, 1993. |
Uldall, P.R., et al., “A Subclavian Cannula for Temporary Vascular Access for Hemodialysis of Plasmapheresis.” Dialysis & Transplantation, vol. 8, No. 10, p. 963, 1979. |
Carbone, Vera, “Hemodialysis Using the PermCath Double Lumen Catheter.” ANNA Journal, vol. 15, No. 3, pp. 171-173, 1988. |
Bregman, Harold, et al., “Minimum Performance Standards for Double-Lumen Subclavian Cannulas for Hemodialysis.” vol. 32, No. 1, 1986. |
Vas-Cath; Soft-cell Permanent Dual Lumen Cannula with Dacron Cuff; Product details; 1988. |
Vas-Cath; Instructions for use of Soft-cell Permanent Dual Lumen Catheter; May 25, 1998. |
Saklayen, “Letters to the editor re: prolonged use of a Subclavian Catheter for Hemodialysis.” Dialysis & Transplantation, Apr. 1998. |
Quinton Instrument Co; Descriptions and Instructions for use of PermCath HemoCath Dual Lumen Catheter; 1984. |
Vas-Cath; Permanent Dual Lumen Catheter for Vas-Cath; Advertisement; Contemporary Dialysis and Nephrology, May 1988. |
Vas-Cath; The Vas-Cath Advantage: Temporary and Permanent Dual Lumen Catheters, Flexxicon® & Flexxicon® Blue brochure. |
Vas-Cath; Temporary Vascular Access Products; Product Line; 1985. |
Shiley; Subclavian Cannulae; Aug. 1986. |
Medcomp; Hemodialysis Products; Product line. |
Impra; Dual Lumen Subclavian Catheter; Information. |
Cook Incorporated; Subclavian Double Lumen Hemodialysis Sets and Trays; U.S. Pat. No. 4,306,562. |
Vas-Cath; Catheter Repair Kit CRK-1 with Titanium Replacement Connector; 1988. |
Vas-Cath; Peritoneal Dialysis Catheters; Indications for use; 1988. |
Vas-Cath; Instructions for use of Flexxicon Dual Lumen Catheters (DLC), Kits (DLK), Trays (DLT); 1988. |
Vas-Cath; Vaccess 2000 Series Single Lumen Subclavian Cannulas (Central Venous Access/Hemodialysis). Brochure distributed by Vas-Cath. |
Vas-Cath; Vaccess 2000 Series Single Lumen Subclavian Cannulas (Single Needle Hemodialysis); 1984. |
Vas-Cath; Vaccess 1000 Series Single Lumen Femoral Cannulas (Hemodialysis); 1984. |
Vas-Cath; For acute dialysis . . . Vas-Cath is accessible; Advertistement; 1987. |
Vas-Cath; Flexxicon Dual Lumen Catheters. Instructions for Use distributed by Vas-Cath. |
Quinton Instrument Company; Peritoneal Dialysis and Hemodialysis; Catalog. |
Aubaniac, Robert. “L'injection intraveineuse sous-claviculaire: Avantages et technique.” La Presse Medicale. 1952. |
Cimochowski, George E., et al., “Superiority of the Internal Jugular over teh Subclavian Access for Temporary Dialysis.” Nephron, vol. 54, No. 2, 1990. |
Duffy, B. J. “The Clinical Use of Polyethylene Tubing for Intravenous Therapy.” Annals of Surgery, vol. 136, No. 5, 1949. |
Erben, Joseph, et al., “Experience with Routine use of Subclavian Vein Cannulation in Haemodialysis.” Dialysis and Renal Transplantation, vol. 6, 1969. |
Hoshal, Verne L., et al., “Fibrin Sleeve Formation on Indwelling Subclavian Central Venous Catheters.” Archives of Surgery, vol. 102, 1971. |
Ratcliffe, P.J. et al., “Massive Thrombosis around Subclavian Cannulas Used for Haemodialysis” The Lancet (Letters to the Editor), vol. 1, No. 8287, 1982. |
Schillinger, F., et al., “Post Catheterisation Vein Stenosis in Haemodialysis: Comparative Angiographic Study of 50 Subclavian and 50 Internal Jugular Accesses”, Nephrology Dialysis Transplantation, vol. 6, No. 10, 1991. |
Shaldon, Stanley, et al., “Hemodialysis by Percutaneous Cathererisation of the Femoral Artery and Vein with Regional Heparinisation.” The Lancet, vol. 2, 1961. |
Twardowski, Zbylut J., “Chapter 57: Peritoneal Catheter Placement and Management.” Suki and Massry's Therapy of Renal Diseases and Related Disorders, Third Edition. |
Young, Warren, “Chapter 14: Elastic Stability”. Roark's Formulas for Stress Strain 1989. |
Vas-Cath; Accessories/Price List for Canadian Hospitals, Hemodialysis Products effecive May 1, 1982. |
Vas-Cath; Vaccess 2 Double-Lumen Subclavian Cannula. |
Vas-Cath; Single Lumen PTFE SubClavian/Femoral Cannulas, Sc-100; Advertisement. |
Vas-Cath; Temporary Vascular Access Products. |
Bregman, Harold, et al.,“The Double-Lumen Subclavian Cannula—A Unique Concept in Vascular Access”. Dialysis & Transplantation, vol. 11, No. 12, pp. 1065-1070, 1982. |
Vas-Cath; Vaccess 2000: Single Lumen Subclavian Cannulas, Instructions for Use—Central Venous Access. |
Vas-Cath; Accessories/Price List. |
Peters, Joseph L., et al., “Long-term venous access.” British Journal of Hospital Medicine, 1984. |
Berlyne, G.M., “Editorial: Hemodialysis versus the Newer Techniques.” Nephron, vol. 27, No. 1, 1981. |
Seldinger, Sven Irar, “Catheter Replacement of the Needle in Percutaneous Arteriography.” Roentgen Diagnostic Department, Karolnska Sjukhuset, Stockholm, Sweden. |
Shaldon, Stanley, et al., “New Developments with Artificial Kidney.” British Medical Journal, London, Jun. 29, 1963. |
Dialysis & Transplantation (A creative Age Publication); vol. 13, No. 8, Aug. 1984. |
Pristave, Robert J., “Medicare Audits.” Dialysis & Transplantation, vol. 12, No. 7, Jul. 1983. |
Bricker, Catherine., “Psychosocial Implications of Nutrition Assessment for Adult Chronic Renal Failure Patients.” Dialysis & Transplantation, vol. 11, No. 5, May 1982. |
Dialysis & Transplantation (A creative Age Publication); vol. 11 No. 6,Jun. 1982. |
Dialysis & Transplantation; vol. 11, No. 7, Jul. 1982. |
Dialysis & Transplantation; vol. 11, No. Aug. 1982. |
Dialysis & Transplantation; vol. 11, No. 9, Sep. 1982. |
Dialysis & Transplantation; vol. 11, No. 11, Nov. 1982. |
Dialysis & Transplantation; vol. 11, No. 12, Dec. 1982. |
Dialysis & Transplantation; vol. 12, No. 1, Jan. 1983. |
Dialysis & Transplantation; vol. 12, No. 2, Feb. 1983. |
Dialysis & Transplantation; vol. 12, No. 3, Mar. 1983. |
Dialysis & Transplantation; vol. 12, No. 4, Apr. 1983. |
Dialysis & Transplantation; vol. 12, No. 5, May 1983. |
Dialysis & Transplantation; vol. 12, No. 6, Jun. 1983. |
Dialysis & Transplantation; vol. 12, No. 7, Jul. 1983. |
Dialysis & Transplantation; vol. 12, No. 8, Aug. 1983. |
Dialysis & Transplantation; vol. 12, No. 9, Sep. 1983. |
Dialysis & Transplantation; vol. 13, No. 5, May 1984. |
Dialysis & Transplantation; vol. 13, No. 6, Jun. 1984. |
Dialysis & Transplantation; vol. 13, No. 7, Jul. 1984. |
Dialysis & Transplantation; vol. 13, No. 9, Sep. 1984. |
Dialysis & Transplantation; vol. 13, No. 10, Oct. 1984. |
Dialysis & Transplantation; vol. 14, No. 3, Mar. 1985. |
Dialysis & Transplantation; vol. 14, No. 5, May 1985. |
Dialysis & Transplantation; vol. 13, No. 8, Aug. 1984. |
Dialysis & Transplantation; vol. 17, No. 6, Jun. 1988. |
Dunn, John, et al., “Centra venous dialysis access: Experience with a dual-lumen, silicone rubber catheter.” Surgery, vol. 102, No. 5, Nov. 1987. |
Twardowski, Zbylut J., “The Need for a ‘Swan-Neck’ Permantently Bent Arcuate Peritoneal Dialysis Catheter.” Peritoneal Dialysis Bulletin, Oct.-Dec. 1985. |
Vas-Cath; Soft-Cell Permanent Dual Lumen Catheter; Insertion Guide. |
Quinton; PermCath and Pediatric PermCath Catheters; Instructions for Use. |
Netter, Frank H.; A compilation of Paintings on the Normal and Pathologic Anatomy and Physiology, Embryology, and Diseases of the Heart; The Ciba Collection of Medical Illustrations, vol. 5. |
Palmer, Russell A., “Treatment of Chronic Renal Failure by Prolonged Peritoneal Dialysis.” The New England Journal of Medicine, vol. 274, No. 5, Feb. 3, 1966. |
Palmer, Russell A, et al., “Prolonged Peritoneal Dialysis for Chronic Renal Failure,” The Lancet, Mar. 28, 1964. |
Vas-Cath; Confidential Training Manual and Marketing Support File for Vascular Access Catheters and Accessories for Dialysis; Revised Jan. 1989. |
Bard; HemoGlide Long Term Hemodialysis Catheter. Instructions for Use for HemoGlide Straight and Precurved (PC) Catheters, with and without VitaCuff © Antimicrobial Cuff, 2002. |
Vas-Cath; Vaccess 2000: Single Lumen Subclavian Cannulas, Instructions for Use—Single Needle Hemodialysis. |
Vas-Cath, “Uldall™ SC-100 Means Quality” Advertisement, 1980. |
Shiley © “Major Improvement. Major Advantage. Shiley's All-Silicone Subclavian Cannual.” Brochure, 1980. |
Vas-Cath, “Go for the Jugular” temporary catheter product advertisement, 1994. |
Quinton et al. “Eight Months' Experience with Silastic-Teflon Bybass Cannulas,” Department of Medicine and Surgery, Universityof Washington and the Quinton Instrument Company, 1961. |
PCT/US2007/008148 filed Apr. 2, 2007 Search Report dated Aug. 28, 2007. |
Number | Date | Country | |
---|---|---|---|
20070233042 A1 | Oct 2007 | US |
Number | Date | Country | |
---|---|---|---|
60744094 | Mar 2006 | US |